Dabigatran etexilate Completed Phase 2 Trials for Coronary Heart Disease (CHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00621855RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome